156 related articles for article (PubMed ID: 10834088)
1. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats].
Gmiro VE; Serdiuk SE
Eksp Klin Farmakol; 2000; 63(2):16-20. PubMed ID: 10834088
[TBL] [Abstract][Full Text] [Related]
2. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
Antonov SM; Johnson JW; Lukomskaya NY; Potapyeva NN; Gmiro VE; Magazanik LG
Mol Pharmacol; 1995 Mar; 47(3):558-67. PubMed ID: 7535380
[TBL] [Abstract][Full Text] [Related]
3. [Bis-ammonium adamantane derivatives--novel modulators of polyamine binding sites].
Gmiro VE; Serdiuk SE
Eksp Klin Farmakol; 2000; 63(3):16-20. PubMed ID: 10934589
[TBL] [Abstract][Full Text] [Related]
4. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Quack G; Hesselink M; Danysz W; Spanagel R
J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
[TBL] [Abstract][Full Text] [Related]
5. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; RodrÃguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
[TBL] [Abstract][Full Text] [Related]
8. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
9. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Kornhuber J; Weller M; Schoppmeyer K; Riederer P
J Neural Transm Suppl; 1994; 43():91-104. PubMed ID: 7884411
[TBL] [Abstract][Full Text] [Related]
10. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440
[TBL] [Abstract][Full Text] [Related]
11. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
[TBL] [Abstract][Full Text] [Related]
12. [Ketamine inhibits n-methyl-d-aspartate (NMDA) receptor mediated acetylcholine release from rabbit caudate nucleus slices].
Feuerstein TJ
Anaesthesist; 1994 Nov; 43 Suppl 2():S48-51. PubMed ID: 7840414
[TBL] [Abstract][Full Text] [Related]
13. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
[TBL] [Abstract][Full Text] [Related]
14. [The search for selective blockers of NMDA and AMPA/kainate receptors in a series of bis-ammonium compounds with adamantyl radicals].
Gmiro VE; Serdiuk SE
Eksp Klin Farmakol; 2000; 63(1):7-13. PubMed ID: 10763102
[TBL] [Abstract][Full Text] [Related]
15. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
Fredriksson A; Archer T
Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
[TBL] [Abstract][Full Text] [Related]
16. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
17. Dizocilpine improves beneficial effects of cholinergic antagonists in anticholinesterase-treated mice.
Dekundy A; Kaminski RM; Turski WA
Toxicol Sci; 2003 Apr; 72(2):289-95. PubMed ID: 12660363
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
Geter-Douglass B; Witkin JM
Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
Levin ED; Petro A; Caldwell DP
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
